This work provides mechanistic insights into the molecular mechanisms underlying cerebellar synaptic dysfunction in ASD, indicating that Grin2b could represent a potential therapeutic target for cognitive impairment. This evidence concerns the gene GRIN2B and Cognitive impairment.